XTL Biopharmaceuticals Ltd. (XTLB)

2.45 -0.25 (-9.36%) USD  |  NASDAQ  |  May 19, 15:55
More

XTL Biopharmaceuticals Return on Net Operating Assets

Return on Net Operating Assets Chart

View Return on Net Operating Assets for XTLB.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Return on Net Operating Assets Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Return on Net Operating Assets Range, Past 5 Years

View Return on Net Operating Assets Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Return on Net Operating Assets Benchmarks

View Return on Net Operating Assets Benchmarks
Start Trial
Compugen Ltd. Upgrade
Pluri, Inc. Upgrade
BioLineRx Ltd. Upgrade
Kamada Ltd. Upgrade
Can-Fite BioPharma Ltd. --